The cell culture market size is projected to reach US$ 52.65 billion by the end of the year of 2030 at a steady CAGR of 10.21% during the forecast period 2022 to 2030, according to latest analysis by Precedence Research.
Market Overview
A recent report provides crucial insights along with application based and forecast information in the global cell culture market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the cell culture market.
The surging awareness regarding the benefits of cell based vaccines, rising prevalence of cancer and other diseases, growing demand for monoclonal antibodies, increasing investments in the cell based research studies, rising focus towards personalized medicines, growing adoption of single use technologies, and rising technological advancements in the cell culture techniques are some of the major factors that are expected to boost the growth of the global cell culture market.
As per the International Agency for Research on Cancer, in 2020, there were around 10 million deaths and 19.3 million new cases of cancer recorded across the globe. The rising prevalence of cancer is significantly boosting the demand for the monoclonal antibodies for the treatment and hence, the demand for the cell culture is bolstering.
Moreover, the rapid emergence and rapidly growing adoption of the 3D cell culture techniques is further fueling the growth of the global cell culture market. The rising investments towards the development of cell based vaccines and drugs is expected to drive the global market during the forecast period. Moreover, the various developmental strategies such as new product launches, mergers, and acquisitions are expected to significantly contribute towards the market growth in the forthcoming future.
Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1803
The main objective of this research report is to define and describe the market and offer a complete valuation of the market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents a breakdown of the market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2022 to 2030.
This research report evaluates the cell culture market on a global and regional level. It offers a thorough analysis of the market status, growth, and forecast of the global cell culture market for the period from 2017 to 2030. This research study offers historic data for the years 2017 to 2020 along with a forecast from 2022 to 2030 based on value.
Report Scope of the Cell Culture Market
| Report Coverage | Details |
| Market Size by 2030 | USD 52.65 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 10.21% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Application, End User, Distribution Channels, Geography |
Report Highlights
- Based on product, the consumables segment dominated the market. The extensive usage of consumables in the research activities and the presence of huge number of research institutes, biopharmaceutical companies, and numerous contract manufacturing and contract research organizations has led to the extensive demand for the consumables across the globe.
- Based on the application, the drug discovery is expected to be the fastest-growing segment. The rising prevalence of various chronic and gene related diseases has fueled the demand for the innovative therapies and vaccines to effectively treat the diseases. The biopharma companies are extensively investing in the drug discovery and development activities to develop new and effective therapies.
Regional Snapshot
North America was the leading cell culture market in 2021. The outbreak of COVID-19 diseases and its rapid spread across the globe has attracted huge investments in the research studies that exponentially contributed to the growth of the cell culture market. Moreover, the North America region is the home to several top biopharmaceutical companies and several contract manufacturing and research organizations that spurs the demand for the cell culture techniques exponentially. The various government policies in US supports the medical research activities as the healthcare is one of the major industries in US. Healthcare expenditure accounted for around 18% of the US GDP in 2018.In 2016, The Human Cancer Models Initiative was undertaken to grow 1,000 new cell line for scientific studies within a period of three years. The favorable government support in medical research studies has significantly fostered the growth of the North America cell culture market.
Asia Pacific is estimated to be the most opportunistic market during the forecast period. The presence of several top research institutes and contract research organizations significantly boosts the demand for the cell culture consumables. The rising demand for the development of various new and innovative drugs and vaccines is bolstering the growth of the Asia Pacific cell culture market.
Market Dynamics
Driver: Surging awareness regarding the advantages of cell-based vaccines
Climate change, rising global population, and rising contact between animals and human has increased the risks of outbreaks of new viruses. Influenza, Swine Flu, and COVID-19 are some examples. This is a major factor that is boosting the need for cell based medical research studies to develop cell based vaccines to treat the various viruses and infections. Previously, the cell culture techniques has helped in the development of vaccines for various diseases such as smallpox, polio, rotavirus, hepatitis, and chickenpox. Therefore, the rising awareness regarding the benefits of cell based vaccines is expected to drive the growth of the cell culture market.
Restraint: High costs involved in cell biology research
The cell biology involves research and development on new therapies like gene therapies and stem cell therapies. A high capital investment is required in the acquisition of various equipment and consumables that facilitates cell based biology research. Moreover, maintaining quality of the research studies and compliances to the regulatory guidelines has fueled the costs involved. Thus the high costs is a major restraining factor in the cell culture market.
Opportunity: Surging demand for the 3D cell culture
The various advantages of the 3D cell culture over the 2D cell culture is boosting the demand for the 3D cell culture techniques. The greater stability and extended life spans of the 3D cell cultures over the 2D counterpart has boosted the adoption of the 3D cell culture across the globe. The rising adoption of the 3D cell culture is expected to drive the market growth in the foreseeable future.
Get Our Latest Press Releases@ https://www.precedenceresearch.com/press-releases
Challenge: Generation of plastic wastes
The extensive usage of the plastic consumables in the cell based research activities generates a huge volume of plastic wastes. Plastics are non-biodegradable are have a negative impact on the environment. The disposal of the plastic wastes has emerged as a major challenge for the market players.
Recent Development
- In October 2019, Thermo Fisher Scientific launched its first cell culture media, which can remain stable when stored at room temperature.
Top Key Players includes in the cell culture market:
- Corning Incorporated
- Merck KGaA
- Sartorius AG
- BioSpherix, Ltd.
- Cell Culture Company, LLC
- Thermo Fisher Scientific Inc.
- VWR International LLC
- Lonza
- Eppendorf AG
- FUJIFILM Irvine Scientific, Inc.
Segments Covered in the Report
By Product
- Equipment
- Centrifuges
- Culture Systems/Bioreactors
- Biosafety Equipment
- Cryostorage Equipment
- Pipetting Instruments
- Incubators
- Cell Culture Vessels
- Others
- Consumables
- Reagents
- Growth Factors & Cytokines
- Albumin
- Protease inhibitor
- Thrombin
- Attachment Factors
- Amino Acids
- Sera
- Fetal Bovine Serum (FBS)
- Others
- Media
- Chemically Defined
- Classical Media
- Lysogeny Broth
- Serum Free
- Protein Free
- Specialty Media
By Application
- Drug Discovery
- Biopharmaceuticals
- Monoclonal antibodies
- Vaccines production
- Other therapeutic proteins
- Tissue Culture and Engineering
- Cell and gene therapy
- Other tissue engineering & regenerative medicine applications
- Vaccine Production
- Gene Therapy
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Other
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Why should you invest in this report?
If you are aiming to enter the global cell culture market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for cell culture are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell Culture Market
5.1. COVID-19 Landscape: Cell Culture Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell Culture Market, By Product
8.1. Cell Culture Market, by Product, 2022-2030
8.1.1 Equipment
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Sera
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Media
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cell Culture Market, By Application
9.1. Cell Culture Market, by Application, 2022-2030
9.1.1. Drug Discovery
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Biopharmaceuticals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Biopharmaceuticals
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Vaccine Production
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cell Culture Market, By End User
10.1. Cell Culture Market, by End User, 2022-2030
10.1.1. Pharmaceutical & Biotechnology Companies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Hospitals & Diagnostic Laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Research & Academic Institutes
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cell Culture Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End User (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End User (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End User (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End User (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End User (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 12. Company Profiles
12.1. Corning Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Corning Incorporated
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Sartorius AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. BioSpherix, Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cell Culture Company, LLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thermo Fisher Scientific Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. VWR International LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Lonza
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Lonza
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. FUJIFILM Irvine Scientific, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1803
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: [email protected]
